Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 394-396, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sweeney, M. J.
Right arrow Articles by Hoffman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sweeney, M. J.
Right arrow Articles by Hoffman, D. H.

Dihydroorotate Dehydrogenase in Liver and Morris Hepatomas

Martin J. Sweeney and David H. Hoffman

The Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46206

Dihydroorotate dehydrogenase (DHODH) activity in the 3683, 3924A, 7288C, and 5123D Morris hepatomas was one-half that of normal rat liver. However, the DHODH activity in Morris hepatoma 7800 was the same as that of rat liver. No correlation existed between the activities of DHODH and the rates of growth of the hepatomas.

The Km's of the DHODH of the hepatomas ranged from 2.5 to 11.5 x 10-5 M and were similar to the Km's of 4.2 x 10-5 for liver from Buffalo rats and 8.25 x 10-5 M for liver from ACI rats. Both rat livers and the five hepatomas had a pH optimum of 8.05 ± 0.1 for DHODH The activity of DHODH from liver was not influenced by fasting, refeeding, or partial hepatectomy in Buffalo and ACI rats, except for an increase in the livers of fasting ACI rats.

Received 8/ 9/72. Accepted 11/ 3/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.